Article Cited by others

MOLECULES OF THE MILLENNIUM

Suvorexant: The first orexin receptor antagonist to treat insomnia

Dubey Ashok K, Handu Shailendra S, Mediratta Pramod K

Year : 2015| Volume: 6| Issue : 2 | Page no: 118-121

   This article has been cited by
 
1 Sleep and itsę disturbanses in chronic obstructive pulmonary disease
A. D. Palman
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018; 118(4): 113
[Pubmed]  [Google Scholar] [DOI]
2 Neuropeptide modulation of addiction: Focus on galanin
Shannyn G. Genders,Karlene J. Scheller,Elvan Djouma
Neuroscience & Biobehavioral Reviews. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 One-pot reaction for the synthesis of N -substituted 2-aminobenzoxazoles using triphenylbismuth dichloride as cyclodesulfurization reagent
Yuki Murata,Natsuho Matsumoto,Maya Miyata,Yuki Kitamura,Naoki Kakusawa,Mio Matsumura,Shuji Yasuike
Journal of Organometallic Chemistry. 2018; 859: 18
[Pubmed]  [Google Scholar] [DOI]
4 The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: a site-specific analysis
Kiyoshi Misawa,Masato Mima,Atsushi Imai,Daiki Mochizuki,Yuki Misawa,Shiori Endo,Ryuji Ishikawa,Takeharu Kanazawa,Hiroyuki Mineta
Clinical Epigenetics. 2018; 10(1)
[Pubmed]  [Google Scholar] [DOI]
5 Sleep Disorders in Patients With Posttraumatic Stress Disorder
Ali A. El-Solh,Usman Riaz,Jasmine Roberts
Chest. 2018;
[Pubmed]  [Google Scholar] [DOI]
6 Tissue Distribution of Suvorexant in Three Forensic Autopsy Cases
Brian Waters,Kenji Hara,Natsuki Ikematsu,Mio Takayama,Aya Matsusue,Masayuki Kashiwagi,Shin-ichi Kubo
Journal of Analytical Toxicology. 2017;
[Pubmed]  [Google Scholar] [DOI]
7 Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA
Ryoji Suno,Kanako Terakado Kimura,Takanori Nakane,Keitaro Yamashita,Junmei Wang,Takaaki Fujiwara,Yasuaki Yamanaka,Dohyun Im,Shoichiro Horita,Hirokazu Tsujimoto,Maki S. Tawaramoto,Takatsugu Hirokawa,Eriko Nango,Kensuke Tono,Takashi Kameshima,Takaki Hatsui,Yasumasa Joti,Makina Yabashi,Keiko Shimamoto,Masaki Yamamoto,Daniel M. Rosenbaum,So Iwata,Tatsuro Shimamura,Takuya Kobayashi
Structure. 2017;
[Pubmed]  [Google Scholar] [DOI]
8 Mechanism of action of suvorexant
Stephen M. Stahl
CNS Spectrums. 2016; 21(03): 215
[Pubmed]  [Google Scholar] [DOI]
9 Ultrasound-assisted synthesis of substituted 2-aminobenzimidazoles, 2-aminobenzoxazoles, and related heterocycles
Wong Phakhodee,Chuthamat Duangkamol,Nittaya Wiriya,Mookda Pattarawarapan
Tetrahedron Letters. 2016; 57(47): 5290
[Pubmed]  [Google Scholar] [DOI]
10 Simple and Highly Sensitive UPLC-ESI-MS/MS Assay for Rapid Determination of Suvorexant in Plasma
Muzaffar Iqbal,Essam Ezzeldin,Nasr Y. Khalil,Sara T. A. Al-Rashood,Khalid A. Al-Rashood
Journal of Analytical Toxicology. 2016;
[Pubmed]  [Google Scholar] [DOI]
11 Chronobesity: role of the circadian system in the obesity epidemic
J. Laermans,I. Depoortere
Obesity Reviews. 2016; 17(2): 108
[Pubmed]  [Google Scholar] [DOI]
12 Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders
Shi-Bin Li,Jeff R. Jones,Luis de Lecea
Current Psychiatry Reports. 2016; 18(1)
[Pubmed]  [Google Scholar] [DOI]
13 Pharmacological profiling of zebrafish behavior using chemical and genetic classification of sleep-wake modifiers
Yuhei Nishimura,Shiko Okabe,Shota Sasagawa,Soichiro Murakami,Yoshifumi Ashikawa,Mizuki Yuge,Koki Kawaguchi,Reiko Kawase,Toshio Tanaka
Frontiers in Pharmacology. 2015; 6
[Pubmed]  [Google Scholar] [DOI]
14 Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Taro Kishi,Shinji Matsunaga,Nakao Iwata,Gianni Virgili
PLOS ONE. 2015; 10(8): e0136910
[Pubmed]  [Google Scholar] [DOI]

 

Read this article